Skip to main content
. 2022 Apr 29;13:894508. doi: 10.3389/fimmu.2022.894508

Figure 1.

Figure 1

Targeting KLRG1 differentially on effector cells and Treg cells may benefit the host during cancer immunotherapy. Functions of KLRG1 signaling on various effector cells as well as Tregs are summarized. Figure was created on BioRender.